PTBP3 Antibody, FITC conjugated

1. Low PTBP1 expression is associated with Prostate Cancer Growth. PMID: 29187400
2. High PTBP3 expression is associated with Epithelial-Mesenchymal Transition in Breast Cancer. PMID: 29187406
3. RTqPCR revealed that the expression level of miR210 and ROD1 in the antimiR210 group was significantly reduced when compared with the NC and BL groups (P<0.05). MiR210 was overexpressed in the serum of prostate cancer patients and transfection with an miR210 inhibitor was able to effectively inhibit the proliferation of prostate cancer cells and promote apoptosis. PMID: 29901117
4. Increased PTBP3 expression is associated with 5- fluorouracil resistance in gastric cancer. PMID: 28222070
5. We propose that miR-210 regulates cell proliferation and apoptosis in glioblastoma multiforme cells by targeting ROD1 PMID: 26443314
6. Data show that polypyrimidine tract-binding proteins nPTB and ROD1 interact with mitochondrial tRNA(Thr) in the cytoplasm outside of mitochondria. PMID: 26657638
7. PTBP3 may promote proliferation and inhibit the differentiation of human gastric cancer MKN45 cells PMID: 25119103
8. ROD1 is a bona fide seedless target of miR-210. PMID: 23024754
9. ROD1 and UPF1 associate with a significant number of common transcripts. PMID: 22575643
10. Regulator of differentiation 1 (ROD1) binds to the amphipathic C-terminal peptide of thrombospondin-4 and is involved in its mitogenic activity. PMID: 19441079

Show More

Hide All

HGNC: 10253

OMIM: 607527

KEGG: hsa:9991

STRING: 9606.ENSP00000334499

UniGene: Hs.269988